Hydrogenology
Hydrogenology editorial study record

Hydrogen-rich saline attenuates vascular smooth muscle cell proliferation and neointimal hyperplasia by inhibiting reactive oxygen species production and inactivating the Ras–ERK1/2–MEK1/2 and Akt pathways

Chen Y, Jiang J, Miao H, Chen X, Sun X, Li Y. · Int J Mol Med. 2013;31(3):597–606.

PreclinicalOther formsPublished 2013
Study record, not medical adviceThis page reports one source and Hydrogenology’s source-text extraction. It does not establish that molecular hydrogen is effective, safe or appropriate for any person. Human, animal and laboratory evidence must not be treated as equivalent.
Source and classification

What kind of evidence is this?

Evidence stream

Preclinical

Reported design

Controlled rat and cell study

Research topic

Cardiovascular and circulatory health

Administration classification

Other forms

Study result signal

Positive preclinical signal.

Outcome type

Vascular histology and mechanistic cell outcomes.

Reported in the source

Methods at a glance

Population or model

Rats after carotid balloon injury and cultured rat vascular smooth-muscle cells.

Sample

Animal group and cell-assay counts were checked in the full article.

Duration

Article-specific animal and cell time points.

Intervention

Daily hydrogen-rich saline in rats and hydrogen-rich culture medium in cell experiments.

Hydrogen form

H₂ dissolved in saline or culture medium.

H₂ specification

Full preparation and exposure details are reported in the checked article.

H₂ flow

Not applicable.

O₂ delivered with H₂

No oxygen was co-delivered.

Comparator

Vehicle-treated injured rats and conventional culture medium.

Reported, not endorsed

Outcomes and reported result

Outcomes measured

Neointimal hyperplasia, cell proliferation and migration, ROS and Ras/ERK/MEK/Akt signaling.

Reported result

The article reports less neointimal hyperplasia and lower stimulated cell proliferation, migration, ROS and pathway activation with the H₂ preparations.

Results-extraction completeness

The full article methods, intervention, outcomes, positive and null findings, funding and conflict statements were checked.

A reported association, difference or mechanism is not automatically a clinical benefit. Null findings, outcome type, study design and precision all matter.

Interpretation limits

Cautions and applicability

Design and reporting cautions

Preclinical evidence only; cell and animal findings do not establish patient benefit.

Applies directly to

The reported balloon-injury and cell models only.

Preliminary appraisal framework

SYRCLE animal-study tool — preliminary

Preliminary risk-of-bias status

Some concerns

Appraisal rationale

Comparator experiments were reported, but allocation concealment and blinded outcome assessment were unclear.

Appraisal domains

Sequence generation checked where reported · Allocation concealment generally unclear · Personnel blinding generally unclear · Outcome-assessor blinding generally unclear · No prospectively registered analysis plan identified

No single-study GRADE certainty rating is assigned. Certainty is assessed by important outcome across a complete eligible evidence set, not by attaching a final grade to one source.

Provenance

Sources and record status

Identifiers

PMID: 23340693 · DOI: 10.3892/ijmm.2013.1256

Publisher access

A free publisher or repository full article was checked.

Extraction basis

Publisher or repository full article and bibliographic record; checked 10 August 2026.

Record revision

2026-08-10